PMID: 11318771Apr 25, 2001Paper

Carbamazepine is not a substrate for P-glycoprotein

British Journal of Clinical Pharmacology
A OwenB K Park

Abstract

To determine whether the anticonvulsant carbamazepine (CBZ), a known CYP3A4 substrate, is also a substrate for the multidrug efflux transporter P-glycoprotein (Pgp). The role of Pgp in the transport of CBZ was assessed in three systems: (a) in mdr1a/1b(-/-) and wild-type mice after administration of 2 mg kg-1 and 20 mg kg-1, which served as a model for brain penetration; (b) in Caco-2 cells, an in vitro model of the intestinal epithelium that is known to express high Pgp levels; and (c) by flow cytometry in lymphocytes using rhodamine 123, a fluorescent substrate for PgP. Brain penetration of both doses of CBZ at 1 h and 4 h was comparable in wild-type and mdr1a/1b(-/-) mice. Transport across the Caco-2 cell monolayer was Pgp-independent, and was not affected by the Pgp inhibitor PSC-833. CBZ had no effect on rhodamine 123 efflux from lymphocytes, in contrast to verapamil, which increased fluorescence intensity fivefold. CBZ is not a substrate for Pgp. Its efficacy is unlikely to be affected by Pgp over-expression in the brain. Furthermore, the interaction of CBZ with drugs that modulate both CYP3A4 and Pgp function such as verapamil is probably due to inhibition of CYP3A4 and not Pgp.

References

Jun 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U A Germann
Feb 7, 1998·The Journal of Clinical Investigation·R B KimG R Wilkinson
Oct 14, 1998·Cancer Metastasis Reviews·P AtadjaD Cohen
Apr 23, 1999·Pharmaceutical Research·R B KimG R Wilkinson
Feb 5, 2000·The New England Journal of Medicine·P Kwan, M J Brodie

❮ Previous
Next ❯

Citations

Mar 7, 2002·Trends in Pharmacological Sciences·Wolfgang Löscher
Aug 2, 2002·Epilepsy Research·Wolfgang Löscher, Dieter Schmidt
Mar 1, 2003·Epilepsy & Behavior : E&B·Graeme J. SillsMartin J. Brodie
Mar 1, 2003·Epilepsy & Behavior : E&B·Michael A. Rogawski
Jul 9, 2011·Pharmacogenetics and Genomics·Caroline F ThornRuss B Altman
Jun 11, 2005·Epilepsia·Dieter Schmidt, Wolfgang Löscher
Jul 17, 2008·Epilepsia·Wolfgang LöscherDieter Schmidt
Mar 12, 2008·Epilepsy Currents·Graeme J Sills
Jan 18, 2006·Acta Pharmacologica Sinica·Jing-jing SunXiao-dong Liu
Sep 25, 2012·Journal of Veterinary Internal Medicine·K R MuñanaK L Mealey
Sep 29, 2005·BMC Neuroscience·Sanjay AwasthiDamir Janigro
Dec 2, 2008·Biological & Pharmaceutical Bulletin·Asako NishimuraNobuhito Shibata
Jul 14, 2011·Indian Journal of Human Genetics·Abhijit DasKurupath Radhakrishnan
Dec 19, 2007·Pharmacogenomics·Guy D LeschzinerMunir Pirmohamed
Apr 10, 2004·Drug Metabolism Reviews·Shufeng ZhouBalram Chowbay
Feb 3, 2007·Expert Opinion on Drug Metabolism & Toxicology·Mary F Paine, Nicholas H Oberlies
Jul 15, 2005·Expert Opinion on Pharmacotherapy·Nicole SoranzoSanjay M Sisodiya
Jul 31, 2007·Expert Opinion on Pharmacotherapy·Sarah K Tate, Sanjay M Sisodiya
Mar 15, 2003·Drug Metabolism Reviews·Shufeng ZhouJames W Paxton
Aug 3, 2006·Journal of Drug Targeting·Andrew Crowe, Yee-Khuan Teoh
Oct 12, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Frédéric MathotV Préat
Aug 26, 2004·The Annals of Pharmacotherapy·Monica A SummersJames W McAuley
Jul 14, 2005·Progress in Neurobiology·Wolfgang Löscher, Heidrun Potschka
Jul 21, 2004·Journal of Psychopharmacology·Shufeng ZhouEdmund J D Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.